"Hormone Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
| Descriptor ID |
D006727
|
| MeSH Number(s) |
D06.347 D27.505.696.399.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hormone Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Hormone Antagonists".
This graph shows the total number of publications written about "Hormone Antagonists" by people in this website by year, and whether "Hormone Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2002 | 2 | 1 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hormone Antagonists" by people in Profiles.
-
Fantasia HC. Elagolix as a Novel Treatment for Endometriosis-Related Pain. Nurs Womens Health. 2019 Aug; 23(4):366-369.
-
Dom?nguez-Ord??ez R, Garcia-Ju?rez M, Lima-Hern?ndez FJ, G?mora-Arrati P, Dom?nguez-Salazar E, Blaustein JD, Etgen AM, Gonz?lez-Flores O. Lordosis facilitated by GPER-1 receptor activation involves GnRH-1, progestin and estrogen receptors in estrogen-primed rats. Horm Behav. 2018 02; 98:77-87.
-
Dom?nguez-Ord??ez R, Garc?a-Ju?rez M, Lima-Hern?ndez FJ, G?mora-Arrati P, Blaustein JD, Gonz?lez-Flores O. Sexual receptivity facilitated by unesterified estradiol: Dependence on estrogen and progestin receptors and priming dose of estradiol benzoate. Behav Neurosci. 2015 Dec; 129(6):777-88.
-
Grow D, Kawwass JF, Kulkarni AD, Durant T, Jamieson DJ, Macaluso M. GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data. Reprod Biomed Online. 2014 Sep; 29(3):299-304.
-
Lee CW, Rickman B, Rogers AB, Muthupalani S, Takaishi S, Yang P, Wang TC, Fox JG. Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res. 2009 Oct 15; 69(20):8166-74.
-
Jacobson-Dickman E, Lee MM. The influence of endocrine disruptors on pubertal timing. Curr Opin Endocrinol Diabetes Obes. 2009 Feb; 16(1):25-30.
-
Engel JB, Audebert A, Frydman R, Zivny J, Diedrich K. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study. Eur J Obstet Gynecol Reprod Biol. 2007 Oct; 134(2):225-32.
-
Cooper BC, Sites CK, Fairhurst PA, Toth MJ. Evidence against a role for ovarian hormones in the regulation of blood flow. Fertil Steril. 2006 Aug; 86(2):440-7.
-
Rothschild AJ. Placebo response in psychotic depression. J Clin Psychiatry. 2005 Dec; 66(12):1615; author reply 1615-6.
-
Braun B, Gerson L, Hagobian T, Grow D, Chipkin SR. No effect of short-term testosterone manipulation on exercise substrate metabolism in men. J Appl Physiol (1985). 2005 Nov; 99(5):1930-7.